Encoded libraries, in vitro biosynthesis of non-standards peptides, new screening methods, novel classes of targets, successful case study, multistep polysaccharide synthesis, design of new synthetic vaccines.



  • KN:  Hiroaki SUGA (The University of Tokyo, JP)

  • IL1: Laurence MULARD (Pasteur Institute, Paris, FR)

  • IL2: Christa MULLER (The University of Bonn, DE)


Innovation in human healthcare to provide the patients with original solutions that address unmet medical needs in terms of treatments (new drugs) or prevention (vaccines) implicates the use of drug design. Several examples will be presented to highlight this aspect of translational medicine.